EMCDDA Home
  • EN
Search

Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (iii) New stimulants (other than cocaine) outpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium022010005248253
Bulgaria02100000303
Czech Republic2520963161260133259391
Denmark2482135231213221153
Germany21210383087437115416897052394
Estonia4211:::::::
Ireland12372000033639
Greece0640000010111
Spain123214722313163536941410
France265114140219910109
Italy21641580000011516131
Cyprus02011000404
Latvia3832281041008325108
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary4015594531710223730373
Malta:611:::::::
Netherlands4114728142831244251495
Austria246123200065267
Poland44231522::::2:
Portugal502220100707
Romania01000000101
Slovenia11:::::::::
Slovakia108329510001280128
Finland01340100119625
Sweden1255261562201180118
United Kingdom6392110939220811253291823133052618
Croatia32462:::::1:
Turkey:::::::::::
Norway:::::::::::
Total844336911804382171114735614216997838
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-11 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013